BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5143348)

  • 1. Isolation of plasmin-free human plasminogen with N-terminal glutamic acid.
    Rickli EE; Cuendet PA
    Biochim Biophys Acta; 1971 Nov; 250(2):447-51. PubMed ID: 5143348
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the isolation of the multiple molecular forms of human plasminogen and plasmin by isoelectric focusing methods.
    Summaria L; Arzadon L; Bernabe P; Robbins KC
    J Biol Chem; 1972 Jul; 247(14):4691-702. PubMed ID: 4261400
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of the NH 2 -terminal glutamic acid and NH 2 -terminal lysine forms of human plasminogen isolated by affinity chromatography and isoelectric focusing methods.
    Summaria L; Arzadon L; Bernabe P; Robins KC
    J Biol Chem; 1973 May; 248(9):2984-91. PubMed ID: 4700448
    [No Abstract]   [Full Text] [Related]  

  • 4. Human plasminogen: in vitro and in vivo evidence for the biological integrity of NH2-terminal glutamic acid plasminogen.
    Collen D; Ong EB; Johnson AJ
    Thromb Res; 1975 Oct; 7(4):515-29. PubMed ID: 1081757
    [No Abstract]   [Full Text] [Related]  

  • 5. Human plasminogen: a summary of studies on its isolation, characterization and activation mechanism.
    Rickli EE
    Immunochemistry; 1975 Jul; 12(6-7):629-32. PubMed ID: 126948
    [No Abstract]   [Full Text] [Related]  

  • 6. Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid.
    Claeys H; Vermylen J
    Biochim Biophys Acta; 1974 Apr; 342(2):351-9. PubMed ID: 4275496
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation and characterization of microplasminogen. A low molecular weight form of plasminogen.
    Shi GY; Wu HL
    J Biol Chem; 1988 Nov; 263(32):17071-5. PubMed ID: 2972717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 9. Measurement of the binding of antifibrinolytic amino acids to various plasminogens.
    Brockway WJ; Castellino FJ
    Arch Biochem Biophys; 1972 Jul; 151(1):194-9. PubMed ID: 5044515
    [No Abstract]   [Full Text] [Related]  

  • 10. The active site of bovine plasminogen activator. Interaction of streptokinase with human plasminogen and plasmin.
    Summaria L; Ling CM; Groskopf WR; Robbins KC
    J Biol Chem; 1968 Jan; 243(1):144-50. PubMed ID: 4229831
    [No Abstract]   [Full Text] [Related]  

  • 11. Streptokinase-dependent delayed activation of horse plasminogen.
    Marcum JA; Highsmith RF; Kline DL
    Biochim Biophys Acta; 1982 Dec; 709(1):19-27. PubMed ID: 6217838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of activation of human plasminogen by streptokinase.
    McClintock DK; Bell PH
    Biochem Biophys Res Commun; 1971 May; 43(3):694-702. PubMed ID: 4254608
    [No Abstract]   [Full Text] [Related]  

  • 13. The isolation and characterization of a ternary human plasmin B-chain-streptokinase-plasminogen complex.
    Summaria L; Boreisha I; Barlow GH; Robbins KC
    Thromb Haemost; 1987 Aug; 58(2):772-7. PubMed ID: 2960030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity chromatography of plasminogen.
    Chibber BA; Deutsch DG; Mertz ET
    Methods Enzymol; 1974; 34():424-32. PubMed ID: 4449462
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolation and characterization of bovine plasminogen activator from a human plasminogen-streptokinase mixture.
    Ling CM; Summaria L; Robbins KC
    J Biol Chem; 1967 Apr; 242(7):1419-25. PubMed ID: 4960668
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasminogen-plasmin system. 3. Kinetics of plasminogen activation and inhibition of plasminogen-plasmin system by some synthetic inhibitors.
    Iwamoto M; Abiko Y; Shimizu M
    J Biochem; 1968 Dec; 64(6):759-67. PubMed ID: 4238017
    [No Abstract]   [Full Text] [Related]  

  • 17. The AH-site of plasminogen and two C-terminal fragments. A weak lysine-binding site preferring ligands not carrying a free carboxylate function.
    Christensen U
    Biochem J; 1984 Oct; 223(2):413-21. PubMed ID: 6437391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen.
    Wallén P; Wiman B
    Biochim Biophys Acta; 1972 Jan; 257(1):122-34. PubMed ID: 4257942
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations.
    Wallén P; Wiman B
    Biochim Biophys Acta; 1970 Oct; 221(1):20-30. PubMed ID: 4248689
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on plasminogen. IX. Purification of human plasminogen from Cohn fraction 3 by affinity chromatography.
    Liu TH; Mertz ET
    Can J Biochem; 1971 Sep; 49(9):1055-61. PubMed ID: 5159592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.